Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Scientific Affairs Director, RELX Intellectual Properties SA
About the author:
Dr. David Evans, Scientific Affairs Director for RELX Intellectual Properties SA, has led Reaxys Inspiring Chemistry efforts since the program’s inception in 2009. He has been with RELX Group (Elsevier’s parent company) in a variety of roles for over 15 years, including journals and books publishing and software product management. He is also board member and the current Chairman of the InChI Trust, a charitable organization founded to support the development of the InChI – the international chemical identifier. David has a BSc and PhD in Chemistry from the University of Bath in the UK.
RELX Intellectual Properties SA is a company within RELX Group dedicated to the management, development and protection of intellectual property. They own a range of databases, publications and trademarks, including The Lancet®, Reaxys®, PharmaPendium®, Embase® and World Travel Market®, which are used under license.
Posts by David Evans
Posted on March 31st, 2016 in Chemistry
I’ve just returned home from the 251st American Chemical Society (ACS) Meeting and Exposition in San Diego. While recovering from my jet lag, Continue reading “Computers + Chemistry: Some Thoughts from ACS San Diego” »
Posted on December 14th, 2015 in Chemistry
After years of hard work, late nights and hours of toil in the lab, the sought after chemistry PhD can aid young scientists towards a successful career. In such a competitive setting, it’s vital to make sure you stand out as a researcher from the start. Continue reading “Propelling tomorrow’s chemistry stars” »
Posted on November 23rd, 2015 in Chemistry
In a wide ranging interview, we find out what Reaxys PhD Prize Winner Dr. Hiroyuki Miyamura has been up to: Continue reading “David Evans Presents: Catching up with Reaxys PhD Prize winner Dr. Hiroyuki Miyamura” »